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Abstract. Two potential substrates namely rice bran and unprocessed brown rice indicated positive result of lovastatin 
existence. Aspergillus niger SAR I, our local isolated fungus, took a responsibility to cooperate with those substrates in 
SSF system. Further experiment including initial profile production, effect of physical parameters (temperature, inoculum 
size and substrate quantity) and final profile production, were carried out. For initial profile, a basic condition of SSF 
which consisted 70% (v/w) of moisture content (adjusted to pH 6.0), 5 g substrates mixture (ungrounded size), 1x107 
spore/ml of inoculum size and incubation temperature at 30±2 0C, was conducted in a flask system and fermented for 7 
days. Those conditions allowed 160.03±3.79 mg lovastatin/g dry substrate of lovastatin production during initial stage. 
After a study of effect of physical parameters, it showed that the optimum temperature was still at ambient temperature 
(30±2 0C) and substrate quantity of 5 g but different inoculum size (1x105 spore/ml). Each parameters specifically 
temperature, inoculum size and substrate quantity produced 253.98±5.92 mg lovastatin/g dry substrate, 297.64±0.56 
mg lovastatin/g dry substrate and 298.72±44.12 mg lovastatin/g dry substrate, respectively. Throughout the final 
profile, the production was 305.08±14.15 mg lovastatin/g dry substrate which made the total increment hit to almost 
91%. In this experiment, lovastatin was subjected into high performance liquid chromatography (HPLC) with acetonitrile 
and phosphoric acid (pH 3.0) as a mobile phase. 
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Introduction 
A report of human mortality is made by World Health Organization (WHO). 23.6 million of 
human race will face death by the year 2030 with cardiovascular diseases (CVD). 
Hypercholesterolemia is the key of this disease and it is controlled by two important cholesterol 
known as high density lipoprotein (good cholesterol) and also low density lipoprotein (bad 
cholesterol). When it comes to hypercholesterolemia condition, reducing LDL level by 
medications is the best option instead of diet and workout. Fungi are a potent microorganism in 
producing a wide fraction of active compounds mostly pharmacological properties. Those 
compounds are dynamically underwent polyketide biosynthetic pathway including statin (anti-
cholesterol agent). Statins are categorized under few classes viz. natural, synthetic and 
combination or modification of natural and synthetic statin. Compactin, lovastatin, pravastatin, 
simvastatin, rosuvastatin, atorvastatin and fluvastatin are the available statins in world’s market. 
According to Praveen and Savitha (2012), the starting production of statin based on acetate units 
linked to each other in a head to tail manner to structure out a polyketide chain. 
Among statins, lovastatin is a common drug that has been used in worldwide as an anti 
cholesterol agent and most hospital in Malaysia prescribed this drug to CVD patients. A core 
mission of lovastatin is to inhibit the rate-limiting enzyme of cholesterol biosynthesis namely 3-
hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) (Pansuriya and Singhal, 2010). There are two 
form of lovastatin; lactone (closed lactone form) and acid (open ring salt). Acid form is an active 
form of lovastatin that functioning to reduce the LDL in blood. The available tablet in our market 
was in native form (lactone). So, once it is carried to the human liver, it will transform into acid 
form and handle its duty as anti-cholesterol agent. An informative report by Marovjan et al. 
(1997) provided a new method in facilitating acid form of lovastatin which is by adding the 
lactone form with water and phosphoric acid. But, the major problem dealing with acid form is its 
stability. 
Lovastatin production has gained large scale importance with more emphasis on use of 
solid substrate fermentation (SSF) approach. This system promises a lot advantages over 
submerged fermentation (SmF) such as higher productivity, simpler operation and lower cost (Li 
and Jia, 2008). However, scientists pay special interest on both systems. Aspergillus, Penicillium, 
Monascus, Paecilomyces, Trichoderma, Scopolariopsis, Doratomyces, Phoma, Phythium, 
Gymnoascus, Hypomyces and Pleurotus are some microorganism generas that been reported by 
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Bizukojc and Stanislaw (2009) and Cabral et al. (2010) as lovastatin producers either under SSF 
or SmF. Based on potentiality of lovastatin production by filamentous fungi in with the 
cooperation of rice bran and bran rice, this project was carried out under SSF condition. Effect of 
three compelling physical parameters towards lovastatin production was investigated. 
 
Materials and Methods 
Microorganism maintenance and inoculum preparation 
A. niger SAR I isolated from Kepala Batas Pulau Pinang (Northern region of Malaysia) was 
used in the present study. It was maintained on potato dextrose agar (PDA) slants, stored at 4 
0C and sub-cultured every fortnightly. Spore inoculum was prepared by adding 10 ml of sterile 
distilled water containing 0.1% (v/v) Tween 80 to a fully sporulated agar slant. The spores were 
dislodged using sterile loop under aseptic condition and serial dilution was done. The spore 
suspension concentration was determined using special square chamber of haemocytometer. 
Solid substrate fermentation in a flask system and production profile of lovastatin 
A basis condition of SSF was applied into a flask system. 70% (v/w) of moisture content, 
5 g substrate mixture (1:1, rice bran: brown rice), 1x107 spore/ml inoculum size and distilled 
water which was adjusted to pH 6.0 using hydrochloric acid and sodium hydroxide. The flasks 
were incubated at ambient temperature, 30±2 0C, for 7 days. A. niger SAR I was applied into 
production profile before and after physical parameters optimization. Profile before physical 
parameters optimization was performed under basis condition while the optimized conditions 
were applied into production profile after physical optimization. Both profiles underwent sixteen 
days of incubation period. 
Temperature, inoculum size and substrate quantity       
Those parameters were the targeted conditions to be optimized. Experiments were 
presented under different temperature ranging from 25 to 400C. For inoculum size, size of 1x104 
to 1x108 spore/ml was tested. In order to testify the effect of substrate size towards lovastatin, 
various quantity was investigated which was 2.5 to 20 g of substrate.    
Extraction and analysis  
A modified method of Szakacs et al. (1998) was selected for extraction purpose. After 48 
hours drying procedure at temperature of 60 0C, substrates were crushed into powder form. 
Then, 1 g of powdery dry substrates was dissolved in 30 ml acetonitrile and shake for 1 hour at 
220 rpm. After that, samples were centrifuged at 3000 gravity for 10 min. The aliquot was 
filtered through nylon syringe filter (pore size of 0.45 µm) and subjected to high performance 
liquid chromatography. The Waters HPLC was supplied with C18 column with the size of 250x4.6 
mm (pore of 5 µm). The eluent system was acetonitrile-phosphoric acid, pH 3.0 (77:23, v/v), 
solution flowing at 1.0 ml/min. The detection wavelength was 238 nm. 
Fungal growth was measured using method of Tsuji et al. (1969) and Swift et al. (1973) by 
taking advantage of chitin existence in cell wall.  
 
Results and Discussion 
The application of basis conditions in a flask system during production profile before 
physical optimization indicated minimum production which was 160.03±3.79 mg lovastatin/g dry 
substrate with 1.31±0.03 mg/g of fungal growth (Figure 1A). After a few physical modifications, 
91% increment was depicted at day tenth which made the total production boost to 
305.08±14.15 mg lovastatin/g dry substrate (Figure 1B).There was no correlation observed 
between lovastatin production and fungal growth. 
Temperature plays an important role in SSF. As shown in Figure 2.0, lovastatin achieved 
its optimum level at ambient temperature (30±2 0C). The influence of A. niger SAR I original 
temperature might affected the temperature selection. However, it has been reported that most 
of microorganism used in SSF was mesophilic, thus the optimal temperature for growth is 
between 20 to 40 0C or below than 500C (Manpreet et al., 2005). In this study, the highest 
production was 253.98±5.92 mg lovastatin/g dry substrate. Figure 3.0 denoted the effect of 
inoculum size which ranged of 1x104 to 1x108 spore/ml towards lovastatin. The optimum size 
was 1x105 spore/ml (297.64±0.56 mg lovastatin/g dry substrate). Size of inoculum initially will 
influence the lag phase of fungal growth. 1x105 spore/ml was suitable for lovastatin production 
as the incubation period was ten day. It allowed fungal to produce maximum level of lovastatin. 
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Figure 1.  Production of lovastatin before physical parameters optimization (A) and after optimization (B). Total increment 
was about 91%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of temperature on lovastatin production by A. niger SAR I after ten days incubation period. 
 
 
 
 
 
 
 
 
Figure 3. Inoculum size 1x105 spore/ml eliminated other sizes as it depicted the highest production of lovastatin 
(Indicator: A= 1x104, B= 1x105, C= 1x106, D= 1x107, E= 1x108 spore/ml) 
A 
B 
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The thicker substrate applied into flask system, the harder A. niger SAR I needed to 
penetrate into the bed as the fungus commonly grow at the surface of substrate. Out of five 
substrate quantities, 5 g substrate gave the best lovastatin production. It provided 
298.72±44.12 mg lovastatin/g dry substrate of lovastatin activity (Figure 4.). 
 
 
 
 
 
 
 
 
Figure 4. Effect of substrate quantities towards lovastatin production by A. niger SAR I 
Conclusions 
Physical parameters attribution was very crucial in producing final product of SSF. Under 
temperature of 30±2 0C, inoculum size of 1x105 spore/ml and 5 g of substrate quantity, 
lovastatin did increase to maximum level. 
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